NewzResearchers at the Weizmann Institute of Science in Tel Aviv have discovered that sildenafil, the erectile dysfunction drug commonly known as Viagra, shows potential in preventing the spread of cancer. Initially developed to treat reduced blood flow, the medication has increasingly demonstrated alternative medical applications as further effects have become understood.
The findings suggest that the blue pill could yield additional therapeutic uses beyond its current applications. The study from the Israeli research team highlights a potential new direction for utilizing the existing pharmaceutical compound in oncology.
In-depth summary · AI, neutral